|
| 36862005 | MicroRNA 483-3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the ERBB3/AKT axis. | Mol Oncol | 2023 |
| 37585503 | Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer. | Sci Transl Med | 2023 |
| 37189167 | Multi-label transcriptional classification of colorectal cancer reflects tumor cell population heterogeneity. | Genome Med | 2023 |
| 37079732 | CONNECTOR, fitting and clustering of longitudinal data to reveal a new risk stratification system. | Bioinformatics | 2023 |
| 37063647 | EGAsubmitter: A software to automate submission of nucleic acid sequencing data to the European Genome-phenome Archive. | Front Bioinform | 2023 |
| 36622698 | Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer. | Clin Cancer Res | 2023 |
| 36759506 | Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT). | Cell Death Dis | 2023 |
| 34635836 | Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin. | Nat Biotechnol | 2022 |
| 35817983 | A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells. | Nat Genet | 2022 |
| 35197630 | Effective drug combinations in breast, colon and pancreatic cancer cells. | Nature | 2022 |
| 34359705 | Synthetic Lethality Screening Highlights Colorectal Cancer Vulnerability to Concomitant Blockade of NEDD8 and EGFR Pathways. | Cancers (Basel) | 2021 |
| 33795873 | Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signalling. | Nat Cell Biol | 2021 |
| 34426441 | Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer. | Clin Cancer Res | 2021 |
| 34217219 | PhyliCS: a Python library to explore scCNA data and quantify spatial tumor heterogeneity. | BMC Bioinformatics | 2021 |
| 34074330 | Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer. | J Exp Clin Cancer Res | 2021 |
| 32430388 | EGFR Blockade Reverts Resistance to KRAS<sup>G12C</sup> Inhibition in Colorectal Cancer. | Cancer Discov | 2020 |
| 33066609 | Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models. | Cancers (Basel) | 2020 |
| 32759276 | Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell-like phenotype. | Sci Transl Med | 2020 |
| 32700762 | Systems analysis of protein signatures predicting cetuximab responses in KRAS, NRAS, BRAF and PIK3CA wild-type patient-derived xenograft models of metastatic colorectal cancer. | Int J Cancer | 2020 |
| 32183295 | Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer. | Cancers (Basel) | 2020 |
| 30698777 | One tool to find them all: a case of data integration and querying in a distributed LIMS platform. | Database (Oxford) | 2019 |
| 31813455 | Immunogenomics of Colorectal Tumors: Facts and Hypotheses on an Evolving Saga. | Trends Cancer | 2019 |
| 31699882 | Adaptive mutability of colorectal cancers in response to targeted therapies. | Science | 2019 |
| 31375513 | Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer. | Clin Cancer Res | 2019 |
| 31287543 | Semalytics: a semantic analytics platform for the exploration of distributed and heterogeneous cancer data in translational research. | Database (Oxford) | 2019 |
| 31253177 | Evolving neoantigen profiles in colorectal cancers with DNA repair defects. | Genome Med | 2019 |
| 31126969 | INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases. | Mol Syst Biol | 2019 |
| 30979792 | INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases. | Mol Syst Biol | 2019 |
| 30971826 | Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. | Nature | 2019 |
| 31164152 | Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models. | J Exp Clin Cancer Res | 2019 |
| 28974546 | A Molecularly Annotated Model of Patient-Derived Colon Cancer Stem-Like Cells to Assess Genetic and Nongenetic Mechanisms of Resistance to Anti-EGFR Therapy. | Clin Cancer Res | 2018 |
| 29990497 | Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer. | Cancer Cell | 2018 |
| 29574251 | Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts. | Neoplasia | 2018 |
| 29538669 | RET fusions in a small subset of advanced colorectal cancers at risk of being neglected. | Ann Oncol | 2018 |
| 28561063 | Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer. | Nat Commun | 2017 |
| 28104906 | Interrogating open issues in cancer precision medicine with patient-derived xenografts. | Nat Rev Cancer | 2017 |
| 29092942 | PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models. | Cancer Res | 2017 |
| 28912576 | Interrogating open issues in cancer medicine with patient-derived xenografts. | Nat Rev Cancer | 2017 |
| 27108243 | Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial. | Lancet Oncol | 2016 |
| 27681291 | Corrigendum: Stromal contribution to the colorectal cancer transcriptome. | Nat Genet | 2016 |
| 27771609 | Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer. | J Natl Cancer Inst | 2016 |
| 27708224 | A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors. | Oncotarget | 2016 |
| 27149858 | Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity. | J Transl Med | 2016 |
| 26843189 | MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations. | Sci Transl Med | 2016 |
| 26787475 | Tankyrase inhibition impairs directional migration and invasion of lung cancer cells by affecting microtubule dynamics and polarity signals. | BMC Biol | 2016 |
| 25706627 | Stromal contribution to the colorectal cancer transcriptome. | Nat Genet | 2015 |
| 26272063 | MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer. | Clin Cancer Res | 2015 |
| 26243863 | HER2 activating mutations are targets for colorectal cancer treatment. | Cancer Discov | 2015 |
| 26296355 | Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas. | Clin Cancer Res | 2015 |
| 26420058 | A diphtheria toxin resistance marker for in vitro and in vivo selection of stably transduced human cells. | Sci Rep | 2015 |